Eight-channel iTRAQ enables comparison of the activity of six leukemogenic tyrosine kinases

被引:207
作者
Pierce, Andrew [1 ]
Unwin, Richard D. [1 ]
Evans, Caroline A. [1 ]
Griffiths, Stephen [1 ]
Carney, Louise [1 ]
Zhang, Liqun [1 ]
Jaworska, Ewa [1 ]
Lee, Chia-Fang [1 ]
Blinco, David [1 ]
Okoniewski, Michal J. [2 ]
Miller, Crispin J. [2 ]
Bitton, Danny A. [2 ]
Spooncer, Elaine [1 ]
Whetton, Anthony D. [1 ]
机构
[1] Univ Manchester, Christie Hosp, Stem Cell & Leukaemia Prote Lab, Manchester M20 4QL, Lancs, England
[2] Univ Manchester, Paterson Inst Canc Res, Bioinformat Grp, Manchester M20 4BX, Lancs, England
关键词
D O I
10.1074/mcp.M700251-MCP200
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
There are a number of leukemogenic protein-tyrosine kinases (PTKs) associated with leukemic transformation. Although each is linked with a specific disease their functional activity poses the question whether they have a degree of commonality in their effects upon target cells. Exon array analysis of the effects of six leukemogenic PTKs (BCR/ABL, TEL/PDGFR beta, FIP1/PDGFR alpha, D816V KIT, NPM/ALK, and FLT3ITD) revealed few common effects on the transcriptome. It is apparent, however, that proteome changes are not directly governed by transcriptome changes. Therefore, we assessed and used a new generation of iTRAQ tagging, enabling eight-channel relative quantification discovery proteomics, to analyze the effects of these six leukemogenic PTKs. Again these were found to have disparate effects on the proteome with few common targets. BCR/ABL had the greatest effect on the proteome and had more effects in common with FIP1/PDGFR alpha. The proteomic effects of the four type III receptor kinases were relatively remotely related. The only protein commonly affected was eosinophil-associated ribonuclease 7. Five of six PTKs affected the motility-related proteins CAPG and vimentin, although this did not correspond to changes in motility. However, correlation of the proteomics data with that from the exon microarray not only showed poor levels of correlation between transcript and protein levels but also revealed alternative patterns of regulation of the CAPG protein by different oncogenes, illustrating the utility of such a combined approach.
引用
收藏
页码:853 / 863
页数:11
相关论文
共 37 条
  • [1] Targeting tyrosine kinases in cancer: The second wave
    Baselga, Jose
    [J]. SCIENCE, 2006, 312 (5777) : 1175 - 1178
  • [2] CONTROLLING THE FALSE DISCOVERY RATE - A PRACTICAL AND POWERFUL APPROACH TO MULTIPLE TESTING
    BENJAMINI, Y
    HOCHBERG, Y
    [J]. JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES B-STATISTICAL METHODOLOGY, 1995, 57 (01) : 289 - 300
  • [3] The biology of CML blast crisis
    Calabretta, B
    Perrotti, D
    [J]. BLOOD, 2004, 103 (11) : 4010 - 4022
  • [4] Genetic abnormalities as targets for molecular therapies in myelodysplastic syndromes
    Cilloni, Daniela
    Messa, Emanuela
    Messa, Francesca
    Carturan, Sonia
    Defilippi, Ilaria
    Arruga, Francesca
    Rosso, Valentina
    Catalano, Renata
    Bracco, Enrico
    Nicoli, Paolo
    Saglio, Giuseppe
    [J]. ESTROGENS AND HUMAN DISEASES, 2006, 1089 : 411 - 423
  • [5] A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome
    Cools, J
    DeAngelo, DJ
    Gotlib, J
    Stover, EH
    Legare, RD
    Cortes, J
    Kutok, J
    Clark, J
    Galinsky, I
    Griffin, JD
    Cross, NCP
    Tefferi, A
    Malone, J
    Alam, R
    Schrier, SL
    Schmid, J
    Rose, M
    Vandenberghe, P
    Verhoef, G
    Boogaerts, M
    Wlodarska, I
    Kantarjian, H
    Marynen, P
    Coutre, SE
    Stone, R
    Gilliland, DG
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (13) : 1201 - 1214
  • [6] Molecular regulation of receptor tyrosine kinases in hematopoietic malignancies
    Correll, Pamela H.
    Paulson, Robert F.
    Wei, Xin
    [J]. GENE, 2006, 374 : 26 - 38
  • [7] Oncogenic Abl and Src tyrosine kinases elicit the ubiquitin-dependent degradation of target proteins through a Ras-independent pathway
    Dai, ZH
    Quackenbush, RC
    Courtney, KD
    Grove, M
    Cortez, D
    Reuther, GW
    Pendergast, AM
    [J]. GENES & DEVELOPMENT, 1998, 12 (10) : 1415 - 1424
  • [8] Oncogenic mechanisms in myeloproliferative disorders
    Delhommeau, F.
    Pisani, D. F.
    James, C.
    Casadevall, N.
    Constantinescu, S.
    Vainchenker, W.
    [J]. CELLULAR AND MOLECULAR LIFE SCIENCES, 2006, 63 (24) : 2939 - 2953
  • [9] Comparative proteomics of primitive hematopoietic cell populations reveals differences in expression of proteins regulating motility
    Evans, CA
    Tonge, R
    Blinco, D
    Pierce, A
    Shaw, J
    Lu, YN
    Hamzah, HG
    Gray, A
    Downes, CP
    Gaskell, SJ
    Spooncer, E
    Whetton, AD
    [J]. BLOOD, 2004, 103 (10) : 3751 - 3759
  • [10] Bioconductor: open software development for computational biology and bioinformatics
    Gentleman, RC
    Carey, VJ
    Bates, DM
    Bolstad, B
    Dettling, M
    Dudoit, S
    Ellis, B
    Gautier, L
    Ge, YC
    Gentry, J
    Hornik, K
    Hothorn, T
    Huber, W
    Iacus, S
    Irizarry, R
    Leisch, F
    Li, C
    Maechler, M
    Rossini, AJ
    Sawitzki, G
    Smith, C
    Smyth, G
    Tierney, L
    Yang, JYH
    Zhang, JH
    [J]. GENOME BIOLOGY, 2004, 5 (10)